| Jolanta Kwiecinska, DPT | |
|
1061 N Broadway, N Massapequa, NY 11758-1853 | |
| (631) 454-6387 | |
| (631) 454-6303 |
| Full Name | Jolanta Kwiecinska |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 1061 N Broadway, N Massapequa, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578895249 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 032076 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jolanta Kwiecinska, DPT 1 Birch Pl, Glen Cove, NY 11542-1468 Ph: (347) 453-4008 | Jolanta Kwiecinska, DPT 1061 N Broadway, N Massapequa, NY 11758-1853 Ph: (631) 454-6387 |
News Archive
The invasion and spread of cancer cells to other parts of the body, known as metastasis, is a principal cause of death in patients diagnosed with breast cancer.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite potential safety concerns, Jazz Pharmaceuticals/UCB's sodium oxybate (JZP-6) will account for more than 15 percent of the fibromyalgia drug market in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Sodium oxybate has demonstrated robust efficacy in Phase III clinical trials for fibromyalgia and interviewed thought leaders are impressed with its effect on several key symptom domains of fibromyalgia, which include pain, sleep and fatigue.
G8 countries should make use of low-cost, effective tools to prevent hunger, disease and premature deaths among women and children in developing countries, Bev Oda, Canada's international cooperation minister, said on Tuesday at the opening of a meeting of G8 development ministers in Halifax, the Toronto Sun reports (Payton, 4/27).
Sunesis Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted voreloxin orphan drug designation for the treatment of acute myeloid leukemia (AML). Sunesis is currently conducting two Phase 2 clinical trials of voreloxin in AML: a single-agent study, known as REVEAL-1, of voreloxin in newly diagnosed elderly AML patients unlikely to benefit from standard induction chemotherapy and a study evaluating voreloxin in combination with cytarabine in relapsed/refractory AML.
› Verified 9 days ago
Richard Salvatore Augeri, PT,DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 117 Greenwood Dr, N Massapequa, NY 11758 Phone: 516-848-9703 Fax: 516-520-8614 | |
Mrs. Christine Martha Malinauskas, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 122 Louis St, N Massapequa, NY 11758 Phone: 516-293-2358 Fax: 516-293-2358 | |
Marci Barry, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 913 N Broadway, N Massapequa, NY 11758 Phone: 516-454-6387 Fax: 516-454-6303 | |
Pequa Physical & Aquatic Therapy, Pllc Physical Therapist Medicare: Medicare Enrolled Practice Location: 913 N Broadway, N Massapequa, NY 11758 Phone: 516-454-6387 Fax: 516-454-6303 | |
Dr. Joseph Caprioli, DPT Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 1344 Hicksville Rd, N Massapequa, NY 11758 Phone: 516-704-7777 Fax: 516-704-7778 | |
Mrs. Melissa Marie Lyons, M.S.,P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1061 N Broadway, N Massapequa, NY 11758 Phone: 516-454-6387 Fax: 516-454-6303 |